Jci_page_head_homepage_01 Jci_page_head_homepage_02
Carlos J. Orihuela, Jafar Mahdavi, Justin Thornton, Beth Mann, Karl G. Wooldridge, Noha Abouseada, Neil J. Oldfield, Tim Self, Dlawer A.A. Ala’Aldeen, Elaine I. Tuomanen
Published in Volume 119, Issue 6
J Clin Invest. 2009; 119(6):1638–1646 doi:10.1172/JCI36759
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 4
CbpA-LR binding determines development of pneumococcal meningitis in vivo.

(A) Schematic representation of the anti-parallel helices that form each of the 2 nearly identical R domains of CbpA (R2 is shown) (24). Square: binding site for pIgR showing amino acids at the turn; circle: putative binding site for LR showing amino acids at the turn. (B) Adherence to rBCEC6 cells of ΔcbpA pneumococci expressing the indicated wild-type or mutant ΔcbpA (100% adherence, 107 ± 14 bacteria/well). *P < 0.001 compared with wild-type; 1-way ANOVA. Error bars indicate SD. CpbA, strain not expressing CbpA protein. (C) Cranial window images (original magnification, ×4) showing adherence of beads bearing wild-type R12 or mutant CbpAP392G-R393G. (D) BALB/c mice were inoculated i.v. with 1 × 106 to 4 × 106 CFU/ml T4 pneumococci. Bacteria were counted in blood and cerebrospinal fluid (CSF) at 18 hours. Circles, wild-type CbpA (n = 10; open circle, mean); X, CbpAP392G-R393G (n = 9; asterisk indicates the mean). Symbols in the gray area were at or below the lower limit of detection.